Holen Sie sich die Stockscreener-App
70.42
0.35%
0.19
Schlusskurs vom Vortag:
$70.23
Offen:
$70.23
24-Stunden-Volumen:
17,384
Relative Volume:
0.05
Marktkapitalisierung:
$1.62B
Einnahmen:
$923.71M
Nettoeinkommen (Verlust:
$84.68M
KGV:
17.86
EPS:
3.9419
Netto-Cashflow:
$182.81M
1W Leistung:
-3.54%
1M Leistung:
-9.93%
6M Leistung:
-5.79%
1J Leistung:
-28.42%
1-Tages-Spanne:
$69.96
$70.76
1-Wochen-Bereich:
$69.96
$74.18
52-Wochen-Spanne:
$69.96
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Firmenname
Ani Pharmaceuticals Inc
Sektor
Telefon
(609) 759-1810
Adresse
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, MN
Compare ANIP vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
70.45 | 1.61B | 923.71M | 84.68M | 182.81M | 3.9419 |
TAK
Takeda Pharmaceutical Co Adr
|
18.30 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.81 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.155 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.48 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
496.69 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-03-12 | Eingeleitet | JP Morgan | Overweight |
| 2024-12-11 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-15 | Eingeleitet | CapitalOne | Overweight |
| 2023-08-22 | Bestätigt | H.C. Wainwright | Buy |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-02 | Eingeleitet | Truist | Buy |
| 2020-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-05-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Bestätigt | Canaccord Genuity | Buy |
| 2017-07-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-02-22 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Eingeleitet | Raymond James | Strong Buy |
| 2016-05-24 | Herabstufung | Standpoint Research | Buy → Hold |
| 2015-11-13 | Eingeleitet | Standpoint Research | Buy |
| 2015-09-28 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Bestätigt | Oppenheimer | Outperform |
| 2015-08-04 | Bestätigt | ROTH Capital | Neutral |
| 2015-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2015-07-15 | Bestätigt | ROTH Capital | Neutral |
| 2015-06-23 | Bestätigt | Oppenheimer | Outperform |
| 2015-05-18 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Bestätigt | Oppenheimer | Outperform |
| 2015-04-10 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Bestätigt | ROTH Capital | Buy |
| 2015-02-18 | Bestätigt | Oppenheimer | Outperform |
Alle ansehen
Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten
ANI Pharmaceuticals stock hits 52-week low at 70.03 USD - Investing.com
ANI Pharmaceuticals (NASDAQ:ANIP) Earns Outperform Rating from Analysts at Leerink Partners - MarketBeat
Legal & General Group Plc Buys Shares of 45,075 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board - Yahoo Finance
ANI Pharmaceuticals to Present at September Investor Conferences - GlobeNewswire
Corient Private Wealth LP Invests $2.01 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) SVP & CFO Stephen Carey Sells 2,850 S - GuruFocus
Ani Pharmaceuticals SVP & CFO Stephen Carey sells $207,480 in stock - Investing.com
ANI Pharmaceuticals (NASDAQ:ANIP) CFO Stephen Carey Sells 2,850 Shares - MarketBeat
79,683 Shares in ANI Pharmaceuticals, Inc. $ANIP Purchased by Jupiter Topco LLC - MarketBeat
ANI Pharmaceuticals (ANIP) CFO sells 2,850 shares in preset trading plan - Stock Titan
Penn Capital Management Company LLC Boosts Holdings in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Man Group plc Makes New Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Precision Trading with Ani Pharmaceuticals Inc. (ANIP) Risk Zones - Stock Traders Daily
Freestone Grove Partners LP Takes $8.39 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Sanctuary Advisors LLC Makes New $1.14 Million Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
ANI Pharmaceuticals (ANIP) director reports holding zero shares - Stock Titan
PDT Partners LLC Makes New Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
How Investors Are Reacting To ANI Pharmaceuticals (ANIP) Board Shake-Up And Strategic Expertise Addition - simplywall.st
ANI Pharmaceuticals (ANIP) President & CEO Nikhil Lalwani Sells 5,400 Shares - GuruFocus
Ani Pharmaceuticals CEO sells $401,220 in company stock By Investing.com - Investing.com Nigeria
ANI Pharmaceuticals (NASDAQ:ANIP) CEO Sells $401,220.00 in Stock - MarketBeat
ANI Pharmaceuticals (ANIP) CEO sells 5,400 shares under trading plan - Stock Titan
ANI Pharmaceuticals CEO Nikhil Lalwani Sells 5,400 Shares via 10b5-1 Trading Plan - Kalkine Media
Nikhil Lalwani plans ANI (NASDAQ: ANIP) stock sale topping $400K - Stock Titan
Is ANI Pharmaceuticals (ANIP) Fairly Priced After Its Board Change? - Sahm
ANI Pharmaceuticals adds Henry Gosebruch to board of directors - Investing.com
ANI Pharmaceuticals adds Henry Gosebruch to board of directors By Investing.com - Investing.com India
ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors - The Manila Times
William Blair Investment Management LLC Takes $21.37 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Faces A Fresh Valuation Test Following Strong 2026 Results - Sahm
NFJ Investment Group LLC Takes $2.77 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Virtus Advisers LLC Makes New Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Quartz Partners LLC Makes New $1.61 Million Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Great Lakes Advisors LLC Buys Shares of 61,481 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Aurora Investment Counsel Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI (ANIP): Rises 1.37% to $77.92 for the Current Session; Boundary Watch: $74.02 and $81.82 Define the Nearby Reference Levels for the Current SessionHigh Dividend Factor - Vinanet
ANI Pharmaceuticals (NASDAQ:ANIP): What Could Shift Sentiment? - Kalkine Media
Rice Hall James & Associates LLC Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
ANI Pharmaceuticals (ANIP) Q2 2026 Earnings Call Transcript - AOL.com
The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance
ANI Pharmaceuticals (ANIP) Could Be 34% Undervalued As Earnings And Guidance Hold - Sahm
Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks - Yahoo Finance
Walleye Capital LLC Buys Shares of 106,112 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Should You Buy ANIP as Low Valuation Meets Cortrophin Execution Risk? - TradingView
ANIP's Cortrophin Guidance Cut Raises the Bar for Second-Half Growth - Yahoo Finance
ANI Pharmaceuticals (ANIP) Insider Sell: SR. VP, GENERAL COUNSEL & SEC. Meredith Cook Sells 500 Shares - GuruFocus
ANI Pharmaceuticals Senior VP Meredith Cook Sells 500 Shares via 10b5-1 Trading Plan - Kalkine Media
Meredith Cook Sells 500 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock - MarketBeat
Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.30%
0.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):